However, the higher ICI response rates of Q4 patients were not associated with tumor PD-L1 expression (Supplementary Fig. 6d), and indeed, within cohort 1, tumor PD-L1 expression did not affect ICI therapy responses (Supplementary Fig. 6e, f). The gene discussed is CD274; the disease is neoplasm.